Jing Pan

2.4k total citations
50 papers, 816 citations indexed

About

Jing Pan is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jing Pan has authored 50 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Jing Pan's work include CAR-T cell therapy research (19 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Jing Pan is often cited by papers focused on CAR-T cell therapy research (19 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Jing Pan collaborates with scholars based in China, United States and Switzerland. Jing Pan's co-authors include Biping Deng, Alex H. Chang, Tong Wu, Zhuojun Ling, Chunrong Tong, Shuangyou Liu, Yuehui Lin, Zhichao Yin, Alex H. Chang and Chao Tong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jing Pan

45 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Pan China 13 542 184 169 131 126 50 816
Swati Naik United States 16 561 1.0× 256 1.4× 238 1.4× 272 2.1× 125 1.0× 90 1.0k
Huiying Qiu China 14 213 0.4× 64 0.3× 119 0.7× 108 0.8× 39 0.3× 91 534
Nora Möhn Germany 16 306 0.6× 39 0.2× 80 0.5× 127 1.0× 30 0.2× 49 699
Christopher D. Scott United States 17 492 0.9× 134 0.7× 179 1.1× 371 2.8× 165 1.3× 43 1.3k
Teresa Fu United States 14 245 0.5× 78 0.4× 240 1.4× 164 1.3× 16 0.1× 19 894
James Scanlon United States 9 594 1.1× 265 1.4× 116 0.7× 218 1.7× 13 0.1× 14 1.4k
Xiaoqin Wu China 13 151 0.3× 56 0.3× 121 0.7× 234 1.8× 27 0.2× 52 634
Nozomu Kawashima Japan 12 111 0.2× 76 0.4× 98 0.6× 63 0.5× 36 0.3× 47 401
Shirley O’Dea Ireland 13 112 0.2× 65 0.4× 276 1.6× 73 0.6× 106 0.8× 29 742
Maria Agelli United States 9 530 1.0× 96 0.5× 58 0.3× 32 0.2× 27 0.2× 13 974

Countries citing papers authored by Jing Pan

Since Specialization
Citations

This map shows the geographic impact of Jing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Pan more than expected).

Fields of papers citing papers by Jing Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Pan. The network helps show where Jing Pan may publish in the future.

Co-authorship network of co-authors of Jing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Pan. A scholar is included among the top collaborators of Jing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Pan. Jing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Jing, Liping Zhao, Samuel Seery, et al.. (2025). Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial. Blood. 146(23). 2745–2757. 1 indexed citations
3.
Zhang, Yibing, Jing Pan, Fan Wu, Zhuojun Ling, & Kai Wang. (2024). Safety and Feasibility of Intrathecal Infusion of CD19 and/or CD22 CAR T Cells in r/r B-ALL Patients with CNSL or High-Risk CNS Relapse. Blood. 144(Supplement 1). 3466–3466.
4.
Tanaka, Daiki, Hiroaki Yaguchi, Kaichi Yoshizaki, et al.. (2024). Behavioral and histological analyses of the mouse Bassoon p.P3882A mutation corresponding to the human BSN p.P3866A mutation. Frontiers in Neuroscience. 18. 1414145–1414145. 1 indexed citations
5.
Pan, Jing. (2023). Chimeric Antigen Receptor T Cell Therapy for Acute Leukemia. PubMed. 6(4). 145–150. 3 indexed citations
6.
Tan, Yue, Liping Zhao, Biping Deng, et al.. (2023). Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia. Journal of Hematology & Oncology. 16(1). 34–34. 49 indexed citations
7.
Pan, Jing, et al.. (2022). Clinical Study of a Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser with Different Parameters in the Treatment of Chloasma: A Randomized-Controlled Trial. Photobiomodulation Photomedicine and Laser Surgery. 40(3). 183–188. 1 indexed citations
8.
Shen, Yuanchao, Jiahao Li, Tianbao Tan, et al.. (2022). Clinical Application of Indocyanine Green Fluorescence Imaging in the Resection of Hepatoblastoma: A Single Institution's Experiences. Frontiers in Surgery. 9. 932721–932721. 10 indexed citations
9.
Pan, Jing, Haiyan Wang, Tiantian Yao, et al.. (2022). Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 10(3). 405–411. 12 indexed citations
10.
Wang, Y. F., Yan Lyu, Xin Wang, et al.. (2022). The effect of influenza A (H1N1) pdm09 virus infection on cytokine production and gene expression in BV2 microglial cells. Virus Research. 312. 198716–198716. 6 indexed citations
11.
12.
Deng, Biping, Jing Pan, Zhaoli Liu, et al.. (2021). Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL. Molecular Therapy — Methods & Clinical Development. 23. 633–643. 10 indexed citations
13.
Deng, Biping, Chuo Li, Weiliang Song, et al.. (2021). Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL. Frontiers in Oncology. 11. 640166–640166. 15 indexed citations
14.
Yang, Tianyou, Wen Yang, Jiahao Li, et al.. (2020). Association of CMYC polymorphisms with hepatoblastoma risk. Translational Cancer Research. 9(2). 849–855. 4 indexed citations
15.
Dong, Ran, Xianghuai Xu, Li Yu, et al.. (2019). Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro‐oesophageal reflux‐induced chronic cough. Alimentary Pharmacology & Therapeutics. 49(6). 714–722. 52 indexed citations
16.
Pan, Jing, Jieyu Yang, Biping Deng, et al.. (2017). High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients. Leukemia. 31(12). 2587–2593. 172 indexed citations
17.
Wang, Can, Ping Wang, Liping Yang, et al.. (2017). Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy. Epilepsy Research. 132. 64–69. 25 indexed citations
18.
Guo, Rui, Bin Lin, Jing Pan, et al.. (2016). Inhibition of caspase-9 aggravates acute liver injury through suppression of cytoprotective autophagy. Scientific Reports. 6(1). 32447–32447. 22 indexed citations
19.
Pan, Jing & Yepeng Guan. (2014). Human-computer Interaction using Pointing Gesture based on an Adaptive Virtual Touch Screen. 11 indexed citations
20.
Pan, Jing. (2004). Clinical effectiveness and safety of candesartan cilexetil in treatment of patients with mild and moderate essential hypertension. Pharmaceutical Care and Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026